Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03600844
Other study ID # TIPTOP_HHS_2018
Secondary ID 2017-13-TIPTOP
Status Completed
Phase N/A
First received
Last updated
Start date April 2, 2018
Est. completion date October 31, 2021

Study information

Verified date March 2022
Source Jhpiego
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study evaluates the effectiveness of community delivery of sulfadoxine-pyrimetamine (SP) for intermittent preventive treatment of malaria in pregnancy (IPTp) in increasing the coverage of IPTp among pregnant women in selected districts in Democratic Republic of Congo (DRC), Madagascar, Mozambique and Nigeria, compared to comparison districts where SP for IPTp is distributed as usual in facilities through routine antenatal care (ANC).


Description:

The specific objectives of this study are to determine the change in the following indicators during the course of the TIPTOP project: 1) Proportion of women who have had a pregnancy that ended in the past 12 months and have received 1 or more, 2 or more and 3 or more doses of IPTp-SP; proportion of women with pregnancy in the past 12 months who attended ANC clinics at least once, and who attended at least four times; proportion of pregnant women attending the first ANC visit before or at week 14; proportion of women who have had a pregnancy that ended in the past 12 months who know about the IPTp service provided by CHWs; and acceptability of C-IPTp for community delivery of IPTp (note: results will be disaggregated by provider type, age, gravidity and distance from facility). To assess these changes, the study will implement structured household surveys targeting potential beneficiaries of the project (pregnant women) in the intervention and comparison areas, implemented at three time points: baseline, mid- and end-points. In each country an initial implementation area (Phase I) and two expansion areas (Phase II) have been selected for the project. This study will establish if community deliver of IPTp is effective and feasible and whether it influences antenatal care service coverage rates. It is expected that the study will provide information to scale up the approach the 4 study countries for the prevention of malaria in pregnancy. This information is also meant to inform global guidelines on community IPTp delivery and may also be used by other countries.


Recruitment information / eligibility

Status Completed
Enrollment 10602
Est. completion date October 31, 2021
Est. primary completion date October 31, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 15 Years to 49 Years
Eligibility Inclusion Criteria: - Women who had a pregnancy that ended in the 12 months preceding the survey - Being resident in the study area during for at least 4 months before the end of the pregnancy - Willing to participate in the household survey (signing informed consent/assent, in line with country guidelines) Exclusion Criteria: - Anyone considered to be a minor in their country. - Not willing to provide informed consent

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Community distribution of SP for IPTp
SP is distributed to eligible pregnant women by trained Community Health Workers (CHWs) at community level. Demand creation activities are implemented within the community as well.

Locations

Country Name City State
Congo, The Democratic Republic of the Bulungu District, Community Setting Bulungu Kwilu
Congo, The Democratic Republic of the Kenge District, Community Setting Kenge Kwango
Congo, The Democratic Republic of the Community Setting Kunda Maniema
Madagascar Mananjary District, Community Setting Mananjary Fianarantsoa
Madagascar Community Setting Toliary 2 Fianarantsoa
Madagascar Community Setting Vohipeno Vatovavy-Fitovinany
Mozambique Meconta District, Community Setting Meconta Nampula
Mozambique Community Setting Murrupula Nampula
Mozambique Nhamatanda District, Community Setting Nhamatanda Sofala
Nigeria Community Setting Akure South Ondo
Nigeria Community Setting Bosso Niger
Nigeria Community Setting Ohaukwu District Ebonyi

Sponsors (2)

Lead Sponsor Collaborator
Jhpiego Barcelona Institute for Global Health

Countries where clinical trial is conducted

Congo, The Democratic Republic of the,  Madagascar,  Mozambique,  Nigeria, 

Outcome

Type Measure Description Time frame Safety issue
Primary IPTp3 Coverage Proportion of women who had a pregnancy ending in the past 12 months and have received three or more doses of IPTp-SP 1 year
Secondary IPTp1 Coverage Proportion of women who have had a pregnancy that ended in the past 12 months and have received one or more doses of IPTp-SP 1 year
Secondary ANC 4 coverage • Proportion of women who have had a pregnancy that ended in the past 12 months and have attended ANC clinics four times 1 year
Secondary ANC 1 Coverage Proportion of women who have had a pregnancy that ended in the past 12 months and have attended ANC clinics at least once 1 year
Secondary Early ANC Coverage Proportion of pregnant women attending the first ANC visit before or at week 14 1 year
Secondary C-IPTp Knowledge Proportion of women who have had a pregnancy that ended in the past 12 months who know about the IPTp service provided by CHWs 1 year
See also
  Status Clinical Trial Phase
Completed NCT03508349 - Routine Antenatal Care Versus Screening and Treatment of Malaria in Pregnancy in Rwanda N/A
Completed NCT01053325 - Establishing Effectiveness of Daily Co-trimoxazole Prophylaxis For Prevention of Malaria in Pregnancy Phase 3
Completed NCT00140517 - Relationships Between the Use of Antimalarial Drugs in Pregnancy and Plasmodium Falciparum Resistance N/A
Recruiting NCT05306067 - Plasmodium Falciparum Genomic Intelligence in Mozambique
Recruiting NCT05757167 - Improving Neonatal Health Through Rapid Malaria Testing in Early Pregnancy With High-Sensitivity Diagnostics Phase 4
Active, not recruiting NCT01555255 - Malaria Rapid Diagnostic Tests (RDTs) in Pregnancy: Detection of Placental Malaria N/A
Completed NCT01136850 - Intermittent Preventive Treatment With Azithromycin-containing Regimens in Pregnant Women in Papua New Guinea Phase 3
Terminated NCT04148690 - Assessing the Impact of Group Antenatal Care on IPTp Uptake in Tanzania N/A
Completed NCT04160026 - Acceptability and Feasibility in the Context of the IMPROVE Trial in Kenya Phase 4
Completed NCT04783051 - Comparison of ISTp- PYRAMAX-US-RDT to IPTp-SP to Prevent Malaria in Pregnant Women in DRC (ULTRAPYRAPREG) Phase 3
Not yet recruiting NCT05348746 - ERASE - Impact of COVID-19 on Malaria Control
Completed NCT03998839 - TIPTOP Sulfadoxine-pyrimethamine (SP) Drug Resistance Study
Completed NCT03208179 - Improving PRegnancy Outcomes With Intermittent preVEntive Treatment in Africa Phase 3
Completed NCT01120145 - Assessment of Sulphadoxine-pyrimethamine for Intermittent Preventive Treatment of Malaria in Pregnancy in Malawi N/A
Completed NCT00730366 - New Approaches to Improve Coverage and Compliance of Antimalarial Treatment for Pregnant Women in Rural Africa Phase 3
Completed NCT00852423 - Safe and Efficacious Artemisinin-based Combination Treatments for African Pregnant Women With Malaria Phase 3
Completed NCT00680732 - Prevention of Intrauterine Growth Retardation in Burkina Faso: the Malaria Component Phase 4
Recruiting NCT03754322 - LAMP Detection of Malaria in PREGnancy (LAMPREG) Trial N/A
Not yet recruiting NCT03944317 - Azithromycin (AZ) and Sulphadoxine-pyrimethamine (SP) for Malaria Prevention in Pregnant Women (IPT-AZ/IPT-SP) N/A
Completed NCT05294406 - Intermittent Preventive Treatment With Dihydroartemisinin-piperaquine in Papua, Indonesia Phase 4